Treatment of Rare SARDS: Systemic Lupus Erythematous and Idiopathic Inflammatory Myopathies

Expert rheumatologists share an overview of the characteristics of SARDs, covering rare disease status, quality of life, and associated comorbidities.

An overview of systemic lupus erythematous including possible causes, prevalence, symptomology, diagnosis, and the goals of therapy.

A brief review of idiopathic inflammatory myopathies, ranging from pathology to the goals of treatment.

Comprehensive insight on the treatment armamentarium for systemic lupus erythematous and nuances in selecting optimal therapy.

Experts take a dive into available therapies and optimal treatment strategies for idiopathic inflammatory myopathies.

Considerations for the role of telemedicine in caring for patients with SARDs, with deference to the challenges of an accurate patient evaluation.

W. Hayes Wilson, MD, and Kostas Botsoglou, MD, reflect on the importance of patient education and advocacy in managing SARDs.

Shared insight on the importance of educating patients with SARDs on the value of COVID-19 vaccination.

Closing out their discussion, experts highlight practical advice for caring for patients with SARDs in the current treatment landscape.